hyperhomocysteinemia
Information
- Disease name
- hyperhomocysteinemia
- Disease ID
- DOID:9279
- Description
- "An amino acid metabolic disorder that involves an abnormally large level of homocysteine in the blood." [url:http\://en.wikipedia.org/wiki/Hyperhomocysteinemia]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT03631238 | Completed | The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions | January 15, 2018 | August 1, 2018 | |
NCT00005338 | Completed | Homocysteine and Progression of Atherosclerosis | August 1991 | August 2004 | |
NCT00005482 | Completed | Homocyst(e)Ine, Vitamin Status, and CVD Risk | September 1995 | March 1999 | |
NCT00005483 | Completed | Plasma Homocysteine Distribution in the United States | December 1994 | July 1999 | |
NCT00317005 | Completed | Phase 4 | Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events | April 2003 | March 2005 |
NCT00473200 | Completed | Phase 1 | Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine | August 2009 | July 2013 |
NCT00626223 | Completed | N/A | 5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients | January 1998 | July 2007 |
NCT00737126 | Completed | N/A | The Effect of Folic Acid Administration in the Progression of Microalbuminuria | January 2004 | December 2005 |
NCT00755664 | Completed | Phase 3 | Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly | July 2007 | September 2012 |
NCT01371357 | Completed | Phase 3 | The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers | May 2011 | December 2011 |
NCT01391416 | Completed | Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients | June 2010 | January 2011 | |
NCT01766310 | Completed | Phase 4 | Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children | December 2012 | March 2013 |
NCT00004495 | Completed | N/A | Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis | June 1999 | September 2000 |
NCT02392767 | Completed | N/A | Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function | October 2014 | August 2015 |
NCT02540642 | Completed | N/A | Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients | October 2010 | May 2015 |
NCT06163443 | Completed | N/A | Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. | March 2, 2022 | May 1, 2023 |
NCT02860338 | Completed | COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE | January 2009 | December 2015 | |
NCT02961972 | Completed | N/A | Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals | January 2015 | June 2017 |
NCT03376490 | Completed | Study of the Association of Muscle Strength, Balance and Other Factors With Vitamin Levels Among Elderly Diabetics | January 1, 2012 | August 31, 2014 | |
NCT03431597 | Completed | Phase 2 | Effectiveness of a Micronutrient Supplement to Lower Plasma Homocysteine MDEG2 Pilot Supplementation Trial | April 26, 2018 | November 26, 2018 |
NCT06264570 | Recruiting | N/A | Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels. | October 23, 2023 | November 30, 2024 |
NCT03720249 | Unknown status | N/A | Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia | May 20, 2019 | December 31, 2022 |
NCT02817503 | Unknown status | Phase 4 | Feasibility Study of the Intensive Systolic Blood Pressure Control | December 2015 | December 2016 |
NCT01871740 | Withdrawn | Phase 4 | CSPPT- Chronic Kidney Diseases Study | May 2008 | August 2014 |
- Disase is a (Disease Ontology)
- DOID:9252
- Cross Reference ID (Disease Ontology)
- MESH:D020138
- Cross Reference ID (Disease Ontology)
- MIM:603174
- Cross Reference ID (Disease Ontology)
- NCI:C84770
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:419503008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0598608
- MedGen concept unique identifier (MedGen Concept name)
- C0598608
- MedGen unique identifier (MedGen Concept name)
- 108623
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020138